Feedback / Questions
buprenorphine/samidorphan (ALKS 5461) - Alkermes
ALKS 5461: Launch in US for MDD in 2019
(Alkermes)
-
Nov 8, 2018 -
Corporate Presentation
Launch US
•
CNS Disorders • Depression • Mood Disorders • Psychiatry
http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-calendar
Nov 8, 2018
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious